In a double-blind, randomized, controlled design, 206 patients with documented cardiovascular disease and treated with hemodialysis for a minimum of 6 months were randomized to treatment with daily supplement of 1.7 g n-3 PUFA or placebo (olive oil) for 3 months.
We present a 2 (Condition) x 3 (Time) double blind, randomized controlled design.
Patients randomized to nutritional supplements, will receive commercially available seal oil for the same duration as the CBT treatment, in a double-blind randomized, controlled design.
We conducted a prospective, double-blinded, randomized, controlled design study to support our hypothesis.
The current study will employ a multi-site, longitudinal, blinded randomized controlled trial (RCT) design with a target sample of 128 patients with schizophrenia (see inclusion criteria below).
A blinded randomized controlled trial with a paired sample design (training group (TG): N = 11; control group (CG): N = 11) consisting of two visits to a sham veterinary practice was carried out.
This study is a two-arm parallel design single blinded randomized controlled trial.
Design: A prospective, blinded, randomized controlled animal study.
We designed this double blinded randomized controlled study to test whether IgM-enriched immunoglobulins administered as rescue treatment in a pneumonia model developing shock, could either limit lung damage and/or contain systemic inflammatory response.
Blinded randomized controlled trial.
